Sign Up to like & get
recommendations!
0
Published in 2021 at "Revue de l'infirmiere"
DOI: 10.1016/j.revinf.2021.07.012
Abstract: Recent therapeutic innovations are significantly changing the management of young children with severe haemophilia. A team from the University Hospital of Nice (06) introduced emicizumab, the first subcutaneous non-replacement therapy. Integrated into the multi-professional management…
read more here.
Keywords:
haemophilia;
practice changes;
management;
major paediatric ... See more keywords